I recently chatted with Bob Archer, the CEO of Newrange Gold Corp. (OTCQB: NRGOF). His company is a gold explorer getting busy in Nevada.
But if you’ve been following me for a while, you may remember Bob as the CEO of Great Panther Mining (NYSE: GPL). That’s a silver miner that made my subscribers a heck of a lot of money back in the day.
So when Bob has something to say about gold — and silver — you’d be wise to listen.
In the following video, Bob laid out his four reasons why gold is going higher. And he also explained his view why silver will lead the way in a precious metals bull market. You can watch that video here …
Direct Link: https://youtu.be/e3JTM42HY-M
Bob and I reference some price action in gold, as well as the gold-silver ratio. So I wanted to share charts of each.
First, here’s a chart showing how gold rammed through the $1,350 price resistance that held it in check for five long years.
You can see that gold has trended higher for years — but every time it tests that overhead resistance, it gets slammed down. But not this week. This week, gold roared on through that barrier. Gold is now trading at six-year highs.
On the bottom of the chart is a momentum indicator that I trust a lot, called “The Force Index.” The Force is now bullish on gold.
And here’s something else that Bob referenced in the video — a chart of the gold-silver ratio.
This chart shows the price of gold divided by the price of silver. It is at extreme levels — just over 90! That means it takes 90 ounces of silver to buy one ounce of gold.
Previous peaks in this ratio have signaled the start of bull markets. And precious metals are overdue for a bull run.
Just some things to think about this weekend. If you aren’t investing in gold and silver miners yet, it’s not too late to start. Heck, after talking to Bob, I just bought Newrange Gold (OTCQB: NRGOF) for my own portfolio. And I expect I’ll buy more companies — explorers, developers, miners — leveraged to gold and silver. I’ll buy them on any pullback.
Just remember, before you buy anything, to do your due diligence.
All the best,
The post An Expert Miner Explains Why Gold is Powering Up — and Silver Will Lead appeared first on The Edelson Institute.
The correction in cannabis stocks could end at any minute, and today’s bargain prices could disappear right along with it.
There’s big money sloshing around the cannabis industry, and it’s only making the massive marijuana megatrend gain more and more strength.
Last week, I showed you “3 Charts for the Next Boom in Cannabis Stocks.” Today, I have three MORE must-see charts for you …
Trend #1: U.S. Cannabis Employment is Booming
Via MJBizDaily.com, we learn that the U.S. Bureau of Labor Statistics has calculated that the total people employed in the marijuana industry in the U.S. is projected to grow 34% this year.
As sales boom and more states legalize, the industry is expected to add roughly 235,000 full-time jobs between now and 2023. This represents a compound annual growth rate of 22%. And this means the industry will provide 475,000 full-time jobs by the end of 2023. Wow!
This is dwarfing growth in the U.S. energy industry, even though the U.S. oil patch is booming as well. Other professions are left far behind.
Meanwhile, marijuana legalization is helping the economy in other ways. The economic impact of cannabis will give the economy a boost of between $39.2 billion to $48 billion this year. That’s about a 35% increase over last year.
Trend #2: Massive Global Growth
Here’s a chart of past and projected global cannabis sales, from ArcView Research …
That’s a compound annual growth rate of 26%. Phenomenal!
This tells us that A) global growth potential is huge, which is great for companies that can capitalize on this megatrend and B) the current pullback is shorter term.
And finally, let’s look at one of the major forces driving legalization … tax revenue.
Trend #3: Tax Revenue is Booming
This chart from Statista is worth a thousand words …
Last year, Washington had the highest tax revenue, an estimated $319 million. California was a close second with $300 million, and Colorado banked $266 million in cannabis taxes. Talk about ringing the cash register!
In fact, Colorado just announced that it has brought in more than $1 billion in tax revenue since legalizing in 2014. You can bet that makes other states green with envy.
This dangling carrot of more tax money is a primary driver that will continue to push legalization this year and beyond.
And D.C. is finally getting onboard …
Just this week, the House of Representatives cast a 267-to-165 vote approving a bipartisan amendment that protects state-legal cannabis programs from interference by the U.S. Department of Justice.
The amendment is attached to the fiscal year 2020 Commerce-Justice-Science spending bill.
Sure, we’ll have to see if it can pass the Senate. But if and when this becomes law, it will lift another cloud of worry from the U.S. cannabis industry.
And so that means NOW — right now — is a great time to put money to work in the cannabis industry … BEFORE it steps further out of the shadows.
All the best,
If you have a 401(k), IRA, or other tax-advantaged retirement account, you can get tax breaks that let you build your nest egg a lot quicker.
But surprisingly, 6 in 10 working-age Americans don’t have one. They’re neglecting one of the BEST ways to grow their wealth.
And if you’re one of the growing number of Americans freelancing — or a part of the gig economy — traditional benefits like 401(k)s just aren’t available.
But you still have options.
Teaser: Just follow a few simple steps >>
The truth is, opening a retirement savings account is a piece of cake.
Just follow a few simple steps:
- If you work for an employer: Ask HR if a plan is available. This will normally be a 401(k) or a 403(b), but other plans exist. You can get the paperwork (or online forms) from HR. Then simply open an account with the administrator your employer has chosen. You’ll need to decide how much money to contribute from each paycheck. The funds are taken out automatically and moved into your account. Some employers will even match an often-large percentage of your contributions!
- If you are self-employed, an independent contractor or freelance: You can open a retirement account on your own. Normally you’ll need to choose between a traditional IRA and a Roth IRA. Traditional IRAs allow you to make tax-deductible contributions. Roth IRAs are contributed to with after-tax money, but you make withdrawals tax-free in retirement. There are also other types of retirement accounts for the self-employed, which may allow bigger contributions.
- Choose a brokerage firm or financial institution: You can open an IRA with pretty much any broker. (Some banks and credit unions also allow you to open an IRA, as do robo-advisers and institutions offering nontraditional investment options, such as peer-to-peer lenders.) Ideally, you’ll want a broker with no fees; low commissions; low or no minimum balance required; and a variety of asset classes you can invest in.
- Open your account: You can almost always do this online. You’ll just need to provide your Social Security number and other financial information. It normally takes just a few minutes.
Once you’ve opened an account, you can start making contributions. Just know there are annual limits on how large your tax-deductible contributions can be.
And you may not be able to deduct IRA contributions if your income is too high and either you or your spouse has a retirement plan at work.
Next, and most importantly, you want to start investing.
Except for robo-advisers, which automatically invest for you, you’ll have to pick your investments and buy them. If you’re not sure where to get started, my monthly newsletter, Wealth Supercycle, is a great place to start.
All the best,
Cannabis-leveraged stocks have been compressing recently, with the benchmark ETFMG Alternative Harvest ETF (NYSE: MJ) down 20% from its March highs.
But these stocks are coiling up like a spring — the next move to the upside in this multibillion-dollar industry could be explosive.
Let me show you three charts that point the way to a potentially massive rally.
First, via Bloomberg and Arcview Market Research, is the projection of legal cannabis stock sales in the U.S. …
U.S. spending on legal marijuana is expected to reach $22.2 billion in 2022. That’s on top of $5.9 billion in Canada.
This tells us that A) global growth potential is huge, which is great for companies that can capitalize on this megatrend, and B) the current pullback is shorter term.
Obviously, companies that can make the most of that trend can do very well indeed.
Second is a chart of projected cannabidiol (CBD) sales in the United States. CBD is a non-psychoactive substance in cannabis. Like its cousin hemp, it has proven medical benefits.
After all, hemp was legalized on a federal level in last year’s farm bill. CBD made from hemp is generally legal, though FDA murkiness on the issue leaves market participants scratching their heads.
Nonetheless, the growth is explosive …
That’s a compound annual growth rate (CAGR) of around 40%. Wow! Select companies that are leveraged to CBD should be on the launch pad.
Finally, I want to show you a chart of Canopy Growth (TSX: WEED) (NYSE: CGC). Why Canopy? Because it is not only the largest cannabis company in the world. It’s an early industry leader with a clear history of leading the entire cannabis sector higher.
|Image credit: StockCharts.com|
On the bottom of the chart is a momentum oscillator called RSI, for relative strength index. Every time Canopy Growth has seen its RSI touch the oversold line on the bottom of the indicator, it has been followed by a rally. Not right away, but soon. Some of those rallies have been extraordinary.
When that “elastic” snaps back, all sorts of cannabis-leveraged stocks could catapult higher.
So … the cannabis market is growing by leaps and bounds. The CBD market is growing even faster. And a leading cannabis-leveraged stock is primed for an explosive move to the upside.
All of this tells me that it’s time to get busy in this industry. Many cannabis stocks are not what I would consider “cheap.” But the best ones are about to get more expensive.
I think the best deal in cannabis stocks right now is the FREE year of my Marijuana Millionaire Portfolio service that I’m offering for a limited time …
That’s 12 months of access to the powerful Weiss Cannabis Stock Rankings … first look at my exclusive video interviews with cannabis-industry insiders … all my newest research on the megatrends that are moving this industry forward (and key stocks higher) … and, best of all, every stock pick based on our $2 million Ranking system and my timely research.
Click here for more information and to claim your free year while you still can.
All the best,
The cannabis industry is seeing stock prices pull back recently. In fact, ALL the leading cannabis stocks are in correction territory.
But that’s OK. It’s pretty great, actually. This gives us an opportunity to load up — on the cheap — for the next big rally.
And we know that rally is coming …
After all, ArcView Market Research, along with BDS Analytics, forecasts that the legal marijuana market is going to grow at a 28% compound annual growth rate through 2022. Globally, the CAGR is 26%.
If that’s not fast enough for you, the CBD market is growing faster. According to the same sources, the U.S. sales of cannabis and hemp-derived CBD products will ramp up to $20 billion by 2024. That’s compound annual growth of 49% between 2018 and 2024!
So when stocks in the industry pull back, it’s a gift. The ETFMG Alternative Harvest ETF (NYSE: MJ) is down 27.7% from its September 2018 highs. Many leading cannabis-leveraged stocks are down even more.
Gift, gift, GIFT!
Speaking of gifts, I’ve created an unusual opportunity for you. You can claim 12 months of my powerful new advisory service … normally $5 grand … for free … right now. I’m talking about my top cannabis stock picks — stocks that are at the top of our Weiss Cannabis Rankings, for the next FULL year. All you need to do is accept my offer, before it disappears. For details, just go here.
And that’s why, when I travel around the country learning about cannabis and speaking at conferences about how to make a fortune in marijuana stocks, I interview many, MANY cannabis-leveraged stocks.
Some of them are great. Like these two videos from the road to cannabis profits I shared with you last week. Here are two more examples …
Dixie Brands (OTC Pink: DXBRF)
Dixie Brands is on the Pink Sheets and trading under $1 a share. It has a market cap of under $100 million. While small, it checks all my boxes.
Why? Because Dixie is consumer products company developing foods and drinks in the cannabis market. The company has built a portfolio of brands focusing on the three markets: human THC, human CBD, and pets.
Dixie operates in five states, including the biggies — California, Colorado and Nevada. It will expand into eight to 10 more this year. It does this through licensing agreements and partnerships with other companies that give Dixie income while it manages the product.
What’s more, Dixie Brands is making huge inroads in the U.S., Canada (in October, when the law changes) and Latin America, starting in Mexico. Its international partnerships include one with Auxly Cannabis Group (OTCQX: CBWTF), which is licensed to sell Dixie-branded products in Mexico and Canada.
While I was at the Benzinga Cannabis Capital Conference in Toronto recently, I interviewed Trip McDermott, V.P. of Corporate Development for Dixie Brands.
|Direct link: https://youtu.be/aAd41DR3CzA|
The company recently reported Q1 earnings. Revenues rose a whopping 136.2% year-over-year, and 40% from Q4.
Sure, it’s not making money yet. It’s losing money because it is putting the pedal to the metal to expand as fast as possible.
This year, it plans to expand into three to five additional U.S. states as well as increase penetration in existing states, in particular California. It also wants to enter the Canadian market.
So, it has lots of room to grow, and it is establishing brands when other cannabis companies are still figuring out distribution channels. Yeah, I think Dixie Brands is going places.
Emerald Health Therapeutics (OTCQX: EMHTF)
While at the Las Vegas MoneyShow, I talked to Allan Rewak, V.P. of Communications and Stakeholder Relations for Emerald Health Therapeutics. This company, based in Canada, has a market cap of $412 million.
It is a seed-to-sale company. But it’s so much more. Watch the video and you’ll see what I mean …
|Direct link: https://youtu.be/fF7OYMwg-fc|
Emerald Health Therapeutics reported earnings at the end of last month. Revenues grew to C$2.6 million, up 602.7% year-over-year. This company is losing money, too, but its loss is getting smaller.
It is expanding rapidly, including rolling out a non-cannabis line of natural health products (Endo) for the endocannabinoid system. That’s a smart move. I keep talking about how the commoditization of cannabis is a risk to the financial health of marijuana growers. They have to diversify into alternate businesses if they’re going to thrive.
Anyway, those are two stocks I think COULD do well. When the time is right, I may recommend them to my Marijuana Millionaire Portfolio subscribers.
Because as I said earlier, the North American cannabis market is going to expand at a CAGR of 28%. These stocks are pulling back now — but no market goes in a straight line. They’re just coiling up for their next big move. A move that could be as extraordinary as it is explosive.
If you’re doing this on your own, do plenty of research.
Relying on Social Security for retirement? That could be the biggest mistake of your life.
First, Social Security benefits have lost a whopping 33% of their buying power since 2000, according to a new report from the nonpartisan Senior Citizens League.
And even though recipients saw a fairly generous cost-of-living adjustment (COLA) in 2019, it was negated by expenses rising even faster.
Second, Social Security is facing a significant shortfall. Come 2034, the trust fund is only expected to collect enough in taxes to pay about 79% of scheduled benefits.
Third, you may be surprised to hear that Social Security was never even meant to function as a sole source of income for seniors.
The Social Security Administration itself says it will replace only 40% of the average worker’s pre-retirement income. But most seniors need double that amount — around 80% — just to pay for basics like housing, food, transportation and healthcare.
Look at the numbers:
The typical Social Security recipient now receives benefits of around $1,360 a month, or $16,320 a year. A dual-income household, therefore, might collect $32,640.
Now look at the costs:
- Healthcare. A healthy 65-year-old couple today can expect to spend $377,000 on healthcare in retirement. That’s at least $18,850 per year over 20 years. (And many seniors live much longer!)
- Housing. About 30% of seniors 65 and over carry mortgage debt. But even if your home is paid off by retirement, you still have maintenance costs. At roughly 4% of an average home’s value each year, you can expect to spend $15,528 a year on your home.
- Transportation. Just because you’re no longer commuting for work, you still need get around town and visit the grandkids. Transportation costs for retirees average $6,852 per year.
- Food. The average senior household forks over $5,508 on food in a year. This figure includes $170 a month dining out. But even if we replace that with 100% home cooking, we’re still talking around $4,140 a year.
- Clothing. While you may not need much in the way of business attire, you can still expect to spend about $1,417 at your local department store.
Adding it all up, we arrive at a minimum of $46,787 …
… meaning you’re ALREADY $14,147 in the hole.
And you’re STILL lacking things like basic cable, internet and cell phone service. Not to mention all those vacations and country club memberships you were looking forward to!
And while you can take steps to lower living expenses, by downsizing, relocating, or taking other drastic measures …
There is a better way.
Grow your nest egg now
The Economic Policy Institute reports that 41% of baby boomers aged 55 to 64 have no retirement savings at all. If you’re part of that statistic, then you need to step up your retirement contributions now.
If you invest wisely, you’d be surprised how large a nest egg you can amass.
And even if you’re already retired, you still have the power to turn things around.
One way is by following my monthly advisory, Wealth Supercycle.
All the best,
Did you catch my real-time cannabis stock training session on Thursday? Discover the secret to picking the highest-quality stocks, and how you can use them to bring in an extra $19k-$20k every month. The replay is online here.
Once you’ve watched that, I have two MORE timely videos to share with you today. They’re interviews with companies in the cannabis space that I find very exciting. And you might find them very profitable.
First up, Las Vegas. I was in town to give a presentation on marijuana profits to the MoneyShow. While, there, I decided to kill two birds with one stoner, and visit the regional HQ of KushCo Holdings (OTCQX: KSHB).
KushCo is a packaging company riding the marijuana megatrend. When a customer buys cannabis or CBD in any form in a store, the packaging, by law, has to be very specific. And each state has its own laws.
It’s a tangled web to navigate, but KushCo is doing just that.
Orders are flying out the door as KushCo helps more than 5,000 cannabis companies — its customers — comply with state and local laws.
The company has other stuff going for it, too, including:
- New packaging for the tsunami of CBD-related products coming to market, AND biodegradable packaging that KushCo is rolling out right now.
- It also sells vaping products.
- It even designs packaging for customers.
- And it has ANOTHER business, distributing hydrocarbon gases used in the production of cannabis oils and concentrates.
I got the scoop on all this from Romina Bollini, the branch manager and key account manager for KushCo Las Vegas. I sat down with her for an interview. You can watch that here …
Direct link: https://youtu.be/07LJOlNImv4
We have some fun in the video, trying out the company’s packaging products. But there’s a lot more to it. Watch the video and see!
KushCo’s share price suffered recently due to an accounting error — by a previous CFO — that led to an earnings restatement for the past two years. But if your eye is on the longer term, the current pullback is just a buying opportunity.
A Prescription for Pot Profits
The next on-the-road interview I want to show is Medicine Man Technologies (OTCQX: MDCL).
Medicine Man has a market cap of just over $112 million. The company has pivoted from being a consulting company (helping people acquire growing licenses) to being a vertically integrated producer. It operates in 18 states.
It is expanding through acquisitions. It even has important acquisitions coming up. Revenues rose 167% year-over-year (yoy) in 2018, while earnings came in at $2.3 million.
I was in Toronto at a cannabis conference recently, and had the opportunity to interview Medicine Man’s COO, Joe Puglise …
Direct link: https://youtu.be/2qOUtvlPMEQ
Since that interview, new earnings and sales numbers have come out. Operating revenues rose 65% yoy in Q1. Product sales grew 233% year-over-year, from $459,335 to $1.5 million. At the same time, the company swung to a loss. It posted a loss of 10 cents per share for the quarter, as it is spending all its money on expansion. Still, the company has positive cash flow, and more than doubled its cash balance.
The company is making important acquisitions — MedPharm Holdings and Medicine Man Denver — which should be finalized in late 2019 or early 2020. These will give the company more retail locations, popular brands and a cannabis research license. The acquisitions should also add another $40 million in revenue.
One thing you should know — I like this company so much, I bought it a while back. I have open gains around 100%. But I think it has so much more potential.
I have more videos like this, and I make more every chance I get. Then, I share them with my Marijuana Millionaire Portfolio subscribers. They like to hear about companies straight “from the horse’s mouth,” and I give them that opportunity first.
There are amazing opportunities in the cannabis space right now. You just have to roll up your sleeves and do the hard work to find them. If you’re doing this on your own, be sure to do your own due diligence. But the next great surge in cannabis stocks is ready to rocket. Don’t wait too long to get onboard.
All the best,
The Fed is manipulating the markets. Why do I think that? Because I’m listening to them!
Fun fact: On Wednesday, the S&P 500 was up 296 points this year. Almost half (143) of those points came on two days, Jan. 4 and June 4.
What did those two days have in common? Monetary-policy remarks from Fed Chairman Jerome Powell.
Now, we can shake our fists at the clouds, and talk about how “unfair” it is. Or we can hoist the Jolly Roger and make money.
I know what I’m going to do. And today, I have one red-hot idea for you.
The Fed Rolls Out the Big Guns
On Monday, St. Louis Fed President James Bullard said the economic outlook had “darkened” in light of trade uncertainty and a rate cut might be needed “soon.” This sparked a brief rally, which faded.
Then, on Tuesday, Fed Chair Jerome Powell said the Fed is prepared to do whatever it takes to keep the U.S. economy rolling along. This includes being ready to “act as appropriate” to sustain the expansion and save the nation from the effects of President Trump’s trade war.
In other words, he’ll consider cutting rates.
Later that same day, Chicago Fed President Charles Evans said he was worried about persistently low inflation. And anyone who’s been up and down Wall Street can tell you that’s Fed code for a potential rate cut, to juice the economy and spark inflation.
On the same day, Federal Reserve Gov. Lael Brainard gave an assist to Powell. She said that the Fed would be “prepared to adjust policy to sustain the expansion” due to uncertainty over trade.
One, Two Three, Four — What Are We Worried For?
So, that’s one-two-three-four (!) Fed governors suddenly sounding dovish. Is that bullish for the markets?
Well, let’s jump into the Way-Back Machine and look at what happened the last time the Fed took a dovish turn. Hey, that was just in January! Here’s a chart …
Image credit: StockCharts.com
Let me take you through the timeline.
Late last year, the market was crashing, and the Fed didn’t help. On Dec. 19, the Fed raised its benchmark interest rate by 25 basis points. And it failed to veer from its path of tightening. In fact, Powell said the Fed was satisfied with its program to reduce the balance sheet and it has no plan to change it. The Fed planned to hike rates twice in 2019.
That hawkish news sent the market crashing to its lows for the year. And in the following days, stocks kept crashing.
This sent President Trump into a tirade. He railed against the Fed in a tweet: “Paris is burning and China way down, the Fed is even considering yet another interest rate hike.”
And on Christmas Eve, President Trump tweeted: “The only problem our economy has is the Fed.”
The carnage stopped in the last week of 2018 as the market enjoyed a “Santa Claus rally.” But that rally started running out of steam.
Powell Changes His Tune
Then, on Jan. 4, Powell changed his tune. Buckling under the pressure from President Trump, he gave the market what it wanted. He said that the Fed would be “flexible” on policy and was in no hurry to raise interest rates.
What did that do? As you can see on the chart, Powell’s “flexible” announcement sparked an 18%, multi-month rally. If you add on the Santa Claus rally, the market soared 25% from its December lows.
Starting in May, we had another pullback. And now, Powell and other Fed governors are coming out to tell the market what it wants to hear — AGAIN!
History may not repeat. But it often rhymes.
And if you want to play this kind of move, you want to invest in something that rhymes REALLY LOUD! (Here’s an idea …)
Now, let’s look at a chart of the performance of the S&P 500 from Jan. 4 — when Powell turned dovish — to April 30, when the market peaked. And I’ll include my choice of loud outperformer.
Image credit: StockCharts.com
You can see that the market went up in the wake of Powell’s dovish turn. A 20.9% gain — nice! But cannabis-leveraged stocks — as tracked by the ETFMG Alternative Harvest ETF (NYSE: MJ) — did VERY well.
In fact, MJ rallied 47% by March 21. But then it began to fade before the broad market. It was still up 35% on April 30, running rings around the broad market.
May was a terrible month for marijuana stocks. As a group, they lost 13%. But you know what, that just put the index back to prices it last saw in January. You know — before it blasted off.
Are marijuana stocks going to blast off again? Will they outpace the broad market? And in turn, will stocks surge on more Fed rate-cut-talk rocket fuel?
I’d say the odds are better than average. And if you want to ride this rocket, MJ — or its components — might be a way to do it.
Want to know how I pick investments in this exciting sector? In this real-time training video I just recorded, you can watch over my shoulder as I analyze the world’s hottest cannabis stocks. Watch it FREE here.
Do your own due diligence before buying anything.
All the best,
I’m gearing up for my real-time cannabis stock trading event this Thursday, June 6th. Learn more about this live broadcast here. In the meantime, I have a fun fact for you:
You and I are chock-full of receptors for cannabinoids.
Because not only are these compounds found in cannabis plants …
Our bodies make their OWN cannabinoids — called endocannabinoids.
If you’re not familiar with the endocannabinoid system (ECS), you’re in for a mind-blowing learning experience.
The ECS is an amazing network of cell-level receptors situated throughout our entire bodies.
In fact, they’re among the most abundant receptors in the brain. And you can also find them in your organs, skin, bones and connective tissues.
Our endocannabinoids bind with the receptors to affect almost every organ.
The goal is to achieve a balance in nearly all metabolic processes.
Dr. Dustin Sulak describes the ECS as “perhaps the most important physiologic system involved in establishing and maintaining human health.”
Happily, cannabis and hemp plants produce “phytocannabinoids” … that also interact with these receptors.
While THC and CBD are the most well-known, there are four “lesser known” but equally important cannabinoids …
CBN — Cannabinol
As harvested cannabis ages, THC is gradually converted to CBN.
CBN is known to be particularly useful for aiding sleep. It’s also good for reducing pain and muscle spasms.
CBG — Cannabigerol
It appears CBG is the molecular building block for all other cannabinoids within the marijuana plant … while having health benefits of its own, like …
Lowering pain and inflammation …
Treating neurological conditions like Huntington’s disease …
Reducing the severity of skin disorders like psoriasis …
And functioning as an antidepressant, a muscle relaxant, an antibiotic and antifungal agent, and as a blood pressure reducer.
CBC — Cannabichromene
Despite being the second most prevalent cannabinoid in many marijuana strains, CBC is mostly unknown.
Not only does it cause no psychoactive effects, it’s been shown to provide a range of health benefits including pain relief, antifungal properties, antidepressant abilities, and even anti-cancer effects.
THCV — Tetrahydrocannabivarin
Known to be an appetite suppressant, THCV also has the potential to help with anxiety, panic attacks, depression and PTSD … without adversely impacting the emotions.
There is also ongoing research to study the effects of THCV in the treatment of Alzheimer’s!
The research that’s already gone into the health benefits of cannabinoids is mind-blowing. There seems to be very little marijuana can’t do …
… with few obvious downsides!
Speaking of mind-blowing, you’re not too late to join me for my first-ever REAL-TIME broadcast event on June 6th:
The Marijuana Millionaire Method Revealed: How to make crazy profits from cannabis stocks, without crazy risks.
As a Wealth Wave reader, you can join in for free … AND get a special gift just for attending. Find out more here.
All the best,
I was recently in Las Vegas, speaking at the MoneyShow. My presentation was “Cannabis Picks for Maximum Profits.” And the hall was packed. Packed! The crowd ranged from young to old. Plenty of seniors want to cash in on the cannabis megatrend.
Since I was in town, I decided to go on a tour of Las Vegas’ cannabis scene. After all, we have medical marijuana in Florida, but it’s very tightly controlled.
The good ol’ boys in Tallahassee are legalizing grudgingly. They reserve most of the money-making opportunities for themselves and their fat-cat friends. So, I wanted to check out Nevada’s more free-wheeling, recreational scene.
To do that, I visited three different dispensaries. Here’s what I learned from my tour of the city …
The Las Vegas ‘Green Light District’
My tour guide was Jeff Johnson, owner/operator of 420 Tours, and his friend and co-worker Brian. They consider themselves “the sherpas of cannabis.”
Jeff is one of those entrepreneurs who has his finger in many pies. One is his tours. Another is cannabis-themed wedding parties that he gives, complete with toasty party favors.
And yet another business Jeff runs has very little to do with THC. When the agriculture department legalized hemp last year, they also tightened up the rules. Now, farmers can’t sell to just anybody. They have to sell to an industrial hemp handler.
That’s what Jeff is. He puts a team together to cut, trim, test and package hemp that he buys from farmers. This hemp can then be sold to retailers or producers who use it as an input in creams, lotions, topicals and so on.
Anyway, Jeff and Brian showed me around. We started with a place called Blackjack Collective. It used to be out in the “Green Light District,” what Jeff calls the warehouse areas where there are about 20 dispensaries.
Blackjack just moved to a fancy new place on the Vegas Strip. And then — even before it had time to put up a proper sign — it was bought by Curaleaf (OTCQX: CURLF).
Curaleaf is America’s largest cannabis retailer. It is building a network of dispensaries across the country. And they seem to favor buying dispensaries with a lot of good local buzz (ha!).
To enter the building, I had to give my driver’s license to a clerk, who checked and registered it. Then we waited around for a “budtender” to take us around the showroom.
Once we got inside the retail area, it was again very clean, and you’ve gotta love an establishment that has customers literally lined up out the door.
The budtenders know their stuff, too. They not only know THC from CBD, but they also know all the different cannabinoids and terpenes and what they do.
Next, we went to a dispensary called Acres. This is smack in the Green Light District. It’s known as a locals’ dispensary. It had an even longer line than Blackjack Collective.
The War on Weed Museum
It also had an awesome museum, which included the history of America’s misguided and racist war on weed.
I actually learned a lot from the wall of Acres. I even saw a 13-star American flag that had been woven from hemp! Do you know that the drafts of the Declaration of Independence were written on hemp paper? You do now.
I also saw people working in a lab, refining raw marijuana.
Extraction experts create the cannabis oil, which is then used to make edibles. The kitchen was closed, unfortunately.
And I learned something about Acres. It has been bought by … Curaleaf.
I am starting to see a theme here.
The Apple of Dispensaries
Next, we went to a store called Planet 13. This is owned by Planet 13 Holdings (OTCQX: PLNHF).
This is a superstore that is sometimes called the “Walmart of Weed.” But I believe that’s wrong. It’s more accurate to call it the “Apple Store” of the cannabis world. I’ll explain why.
Planet 13 has long display cases filled with examples of premium weed. It also showcases brands endorsed by celebrities.
Mike Tyson, for example, is a weed entrepreneur, and has a 40-acre marijuana destination resort in California called “Tyson Ranch.” Here in Las Vegas, at Planet 13, he has some of his favorite marijuana displayed alongside a pair of his boxing gloves.
Planet 13 was also giving out samples of CBD gummies. Yummy! Those things were delicious. I had three. Others had more.
More thoughts …
- At Planet 13, Jeff pointed out that groups of ladies were shopping for cannabis together. “It used to be, ‘I’ll smoke what my boyfriend is smoking,’ ” he said. “Legalization has taken the stigma off.”
- Planet 13 charges premium prices for most of the stuff it sells. People pay twice there what they would at, say, the Blackjack Collective. Why do more than a thousand people a day shop there, then? Because Planet 13 offers an experience akin to an Apple Store along with a celebrity chaser. The “cool” factor is off the charts.
- Everything from the hemp that Jeff and Brian packaged at their shop to all the myriad products sold at every dispensary I visited requires very exact packaging.
Could Las Vegas Become
America’s Cannabis Capital?
Public consumption of cannabis (either medical or recreational) is illegal and remains punishable by law across the state of Nevada.
Marijuana lounges were just legalized in Las Vegas. The plan was to roll out regulations, and then get the lounges up and running in six months. Licenses for cannabis lounges will only be awarded to those businesses already approved to operate dispensaries. That could see use become even more open. This could, in fact, turn Las Vegas into the Amsterdam of North America.
And that means Las Vegas — already a tourist destination — could become even more of one.
But not so fast …
Nevada has just passed a law setting up a Cannabis Advisory Commission. And as part of that, Nevada Gov. Steve Sisolak is kicking the can down the road for two years on marijuana lounges.
The law could change again. After all, cannabis companies have inordinate amounts of cash. And the older I get, the more I realize it is money, not people, that make laws.
I’ll keep my eye on Nevada, as they try to navigate the cannabis megatrend. I’ve named a couple companies that are leveraged to that trend. But before you buy anything, do your own due diligence.
Even better, you can look over my shoulder to see how I pick cannabis stocks at my first-ever live training event!
Starting this coming Monday, June 10, I’ll show you a brand-new way to book big gains in cannabis investments, without the crazy risks so many folks are taking right now.
That kicks off four days where I’ll reveal …
- Day 1 (Monday): The current state of the cannabis boom … and where it’s likely headed over the next several months.
- Day 2 (Tuesday): The biggest trends shaping the profit opportunities in cannabis right now.
- Day 3 (Wednesday): My most powerful indicators for pinpointing specific pot stocks poised to explode higher in the next 30 days.
- And on Day 4 (Thursday), you can join me for a streaming video broadcast, and watch over my shoulder as I analyze the world’s hottest cannabis stocks … in real time!
As a longtime reader, you’ll get full access for FREE. Just click here now and sign up for the training to receive all these benefits and more.
All the best,